DHG Pharmaceutical JSC

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.30% vs -5.08% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 18.60% vs 19.85% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,198,100.20",
          "val2": "1,194,544.80",
          "chgp": "0.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "358,692.00",
          "val2": "314,501.50",
          "chgp": "14.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "6,242.80",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "305,707.00",
          "val2": "257,752.70",
          "chgp": "18.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "274.80%",
          "val2": "238.80%",
          "chgp": "3.60%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.82% vs -2.60% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.45% vs -25.91% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,266,962.70",
          "val2": "4,884,867.70",
          "chgp": "7.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,070,899.70",
          "val2": "1,031,482.00",
          "chgp": "3.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "25,689.90",
          "val2": "24,886.20",
          "chgp": "3.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "824,783.50",
          "val2": "753,552.50",
          "chgp": "9.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "180.70%",
          "val2": "176.40%",
          "chgp": "0.43%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

1,198,100.20

1,194,544.80

0.30%

Operating Profit (PBDIT) excl Other Income

358,692.00

314,501.50

14.05%

Interest

0.00

6,242.80

-100.00%

Exceptional Items

0.00

0.00

Consolidate Net Profit

305,707.00

257,752.70

18.60%

Operating Profit Margin (Excl OI)

274.80%

238.80%

3.60%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 0.30% vs -5.08% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 18.60% vs 19.85% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

5,266,962.70

4,884,867.70

7.82%

Operating Profit (PBDIT) excl Other Income

1,070,899.70

1,031,482.00

3.82%

Interest

25,689.90

24,886.20

3.23%

Exceptional Items

0.00

0.00

Consolidate Net Profit

824,783.50

753,552.50

9.45%

Operating Profit Margin (Excl OI)

180.70%

176.40%

0.43%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 7.82% vs -2.60% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 9.45% vs -25.91% in Dec 2024

All Annual Results